These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20561053)

  • 21. Comparative proteomics in neurodegenerative and non-neurodegenerative diseases suggest nodal point proteins in regulatory networking.
    Zabel C; Sagi D; Kaindl AM; Steireif N; Kläre Y; Mao L; Peters H; Wacker MA; Kleene R; Klose J
    J Proteome Res; 2006 Aug; 5(8):1948-58. PubMed ID: 16889417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nerve growth factor in neurodegeneration and neurorestorative therapy].
    Lorigados-Pedre L; Bergado-Rosado J
    Rev Neurol; 2004 May 16-31; 38(10):957-71. PubMed ID: 15175980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-synuclein: normal function and role in neurodegenerative diseases.
    Norris EH; Giasson BI; Lee VM
    Curr Top Dev Biol; 2004; 60():17-54. PubMed ID: 15094295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metallothioneins are multipurpose neuroprotectants during brain pathology.
    Penkowa M
    FEBS J; 2006 May; 273(9):1857-70. PubMed ID: 16640552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transient coexpression of nestin, GFAP, and vascular endothelial growth factor in mature reactive astroglia following neural grafting or brain wounds.
    Krum JM; Rosenstein JM
    Exp Neurol; 1999 Dec; 160(2):348-60. PubMed ID: 10619552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study on structure-property-reactivity-function relationship of human neuronal growth inhibitory factor (hGIF).
    Ding ZC; Zheng Q; Cai B; Ni FY; Yu WH; Teng XC; Gao Y; Liu F; Chen D; Wang Y; Wu HM; Sun HZ; Zhang MJ; Tan XS; Huang ZX
    J Inorg Biochem; 2008 Nov; 102(11):1965-72. PubMed ID: 18757100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation at Glu23 eliminates the neuron growth inhibitory activity of human metallothionein-3.
    Ding ZC; Teng XC; Cai B; Wang H; Zheng Q; Wang Y; Zhou GM; Zhang MJ; Wu HM; Sun HZ; Huang ZX
    Biochem Biophys Res Commun; 2006 Oct; 349(2):674-82. PubMed ID: 16945328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metallothioneins I and II: neuroprotective significance during CNS pathology.
    Stankovic RK; Chung RS; Penkowa M
    Int J Biochem Cell Biol; 2007; 39(3):484-9. PubMed ID: 17097331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
    Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
    Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noradrenergic mechanisms in neurodegenerative diseases: a theory.
    Marien MR; Colpaert FC; Rosenquist AC
    Brain Res Brain Res Rev; 2004 Apr; 45(1):38-78. PubMed ID: 15063099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zinc: indications in brain disorders.
    Prakash A; Bharti K; Majeed AB
    Fundam Clin Pharmacol; 2015 Apr; 29(2):131-49. PubMed ID: 25659970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization, regulation, and function of metallothionein-III/growth inhibitory factor in the brain.
    Sogawa CA; Asanuma M; Sogawa N; Miyazaki I; Nakanishi T; Furuta H; Ogawa N
    Acta Med Okayama; 2001 Feb; 55(1):1-9. PubMed ID: 11246971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of neuronal growth inhibitory factor (metallothionein-3) in polyacrylamide gels and by Western blot analysis.
    Meloni G; Knipp M; Vasák M
    J Biochem Biophys Methods; 2005 Jul; 64(1):76-81. PubMed ID: 15982745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A role for extracellular metallothioneins in CNS injury and repair.
    Chung RS; West AK
    Neuroscience; 2004; 123(3):595-9. PubMed ID: 14706772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Introduction: Neuroimaging of degenerative and traumatic encephalopathies.
    Law M; Wintermark M; Liu C; Van Horn JD
    Neurosurg Focus; 2015 Nov; 39(5):E1. PubMed ID: 26646925
    [No Abstract]   [Full Text] [Related]  

  • 37. Current world literature.
    Curr Opin Neurol; 2012 Dec; 25(6):802-8. PubMed ID: 23160426
    [No Abstract]   [Full Text] [Related]  

  • 38. Growth-inhibitory factor, metallothionein-like protein, and neurodegenerative diseases.
    Uchida Y
    Biol Signals; 1994; 3(4):211-5. PubMed ID: 7834016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zn2+ decoration of microtubules arrests axonal transport and displaces tau, doublecortin, and MAP2C.
    Minckley TF; Salvagio LA; Fudge DH; Verhey K; Markus SM; Qin Y
    J Cell Biol; 2023 Aug; 222(8):. PubMed ID: 37326602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metallothionein 3 Inhibits 3T3-L1 Adipocyte Differentiation via Reduction of Reactive Oxygen Species.
    Li Y; Lee SH; Piao M; Kim HS; Lee KY
    Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36978888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.